• Vertex’s cystic fibrosis drugs become publicly available in Denmark pharmaceutical
    November 19, 2018
    Vertex Pharmaceuticals has signed an access agreement with Denmark’s pharmaceutical procurement agency Amgros for public hospital use of all current and future drugs for mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
PharmaSources Customer Service